Treatment with Genetically Altered Viruses Targets and Destroys Ovarian Cancer in Mice
Researchers have successfully eliminated chemotherapy-resistant ovarian cancer cells in mice using a single injection of two viruses genetically combined and altered to be safe, leading to long-term survival and demonstrating a potential breakthrough treatment for women.
Once-Common Hysterectomy Technique Linked to Worse Uterine Cancer Outcomes
Every year, nearly 700,000 American women have surgery to remove their uterus (hysterectomy) or uterine fibroids (myomectomy). A laparoscopic surgical technique once commonly used in these procedures could be worsening the outcomes for women who have undiagnosed uterine cancer at the time of the procedure, Yale Cancer Center scientists report in the Journal of Clinical Oncology.
Statement concerning recall of Allergan breast implants following cancer link
At the request of the U.S. Food and Drug Administration, textured breast implants made by Allergan are being recalled. The implants have been linked to a rare cancer called Anaplastic Large Cell Lymphoma. Dr. Tomer Avraham comments.
Expanded insurance coverage for breast cancer screenings lauded by officials, advocates
Harrowing tales from breast cancer survivors from across the state and a slip-up from a freshman legislator are among the circumstances that led to the passage of a bill expanding health care coverage for annual breast cancer screenings.Source: CT Mirror
More women in U.S. receive 3-D mammography but disparities remain
Use of 3-D mammography, an advanced form of breast cancer screening, has risen rapidly in recent years, according to Yale Cancer Center researchers in a new study. But adoption of the technology varies widely, reflecting emerging disparities in care, they said.
8 Ways to Be There for Yourself After a Breast Cancer Diagnosis
Although learning to cope after a breast cancer diagnosis is a really individual process, experts and survivors we spoke with emphasized that there are a few ways you might be able to make the experience even a little bit easier. Here are their suggestions.Source: Self Magazine
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as CT Magazine 'Best Doctors'
Connecticut Magazine has named 72 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2019 Best Doctors guide. Published in the magazine’s June issue, the Best Doctors list consists of 782 Connecticut physicians from 78 medical specialties.
Greenwich woman helps lead early detection battle against ovarian, breast cancers
GREENWICH — Greenwich Hospital will spearhead an effort to help doctors better recognize the symptoms and signs of ovarian cancer and breast cancer and more effectively diagnose the potentially deadly diseases.Source: Greenwich Time
Greenwich Hospital and the Town of Greenwich partner to announce a new program to screen earlier for Breast and Ovarian Cancers
Greenwich, CT (May 1, 2019) – Greenwich Hospital will launch a new physician education program to help all doctors recognize potential early signs of breast and ovarian cancer in an effort to diagnose both diseases much sooner. Called the MAT Education Program, the curriculum was developed by physicians at Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center at the behest of Greenwich resident Kaile Josephs Zagger who lost her mother, Marilyn Ann Trahan (MAT) 20 years ago to ovarian cancer.
Breaking it Down: How the Chemistry of Digestion is Uncovering Sex-Specific Causes of Colon Cancer
A new technology called metabolomics allows researchers to explore the small chemicals formed and used during digestion as a window into the formation of diseases such as colon cancer, seeking early warning signs and potent tactics for prevention.
Knowing the Risks: The Genetics of Breast and Ovarian Cancer
Dr. Ryan Jensen’s work, spurred by a pair of WHRY grants, continues progress toward models uncovering how genetic mutations lead to cancer and helping guide patients and doctors toward decisions that can produce the best health outcomes.
Opportunities to vaccinate young women against HPV missed at alarming rate
en aged 18-26 who were eligible to receive Human Papilloma Virus (HPV) vaccine have missed at least one opportunity to receive the vaccine during a visit to an obstetrics and gynecology clinic, Yale researchers report. This study also confirms previous research showing racial disparities in vaccination for HPV: Women who identify as black are 61% more likely have had a missed opportunity than women who identify as white. These findings are published in the American Journal of Obstetrics and Gynecology. HPV is a well-known cause of pre-cancerous cervical lesions, which, if untreated, could develop into cervical cancer. Immunization against HPV has been shown to be safe and effective in preventing these pre-cancerous lesions. The two-dose HPV vaccine is recommended for administration to It is recommended that girls ages 11-12 receive the two-dose HPV vaccine, and that those through age 26 receive the three-dose vaccination for “catch-up.”